Cargando...
Economic impact of olaparib on maintenance treatment of patients with BRCA-mutation positive, platinum-sensitive relapsing high-grade serous epithelial ovarian cancer in Spain
Objective: To estimate the economic impact of the introduction of olaparib in the Spanish National Health System as maintenance monotherapy in patients with BRCA-mutation positive high-grade serous ovarian cancer. Method: A budget impact model was developed from the Spanish NHS perspective and a ti...
Guardado en:
Publicado en: | Farmacia Hospitalaria |
---|---|
Autores principales: | , , , , , |
Formato: | Artigo |
Lenguaje: | Inglês |
Publicado: |
Sociedad Española de Farmacia Hospitalaria
2018
|
Materias: | |
Acceso en línea: | https://www.redalyc.org/articulo.oa?id=365962462003 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|